Disregulasi Respon Imun pada Kanker Payudara: Tinjauan Epidemiologi, Subtipe Molekuler, dan Terapi
DOI:
https://doi.org/10.63822/rw6rbs87Keywords:
immune dysregulation; breast cancer; tumor microenvironmentAbstract
Breast cancer is the disease with the highest mortality rate in women worldwide. Breast cancer development is influenced not only by the intrinsic characteristics of tumor cells but also by the complex interactions between cancer cells, the immune system, and components of the tumor microenvironment (TME). Dysregulation of the immune response plays a crucial role in disease progression through various mechanisms, including immunosuppression, immune evasion, and altered immune cell function. This article aims to comprehensively examine the mechanisms of immune response dysregulation in breast cancer based on the latest scientific literature. The method used is a literature review by reviewing various relevant research articles and review articles regarding breast cancer molecular subtypes, TME characteristics, the role of immune cells, and factors influencing the immune response in breast cancer. The results of this study indicate that breast cancer molecular subtypes have distinct immunological characteristics that influence disease progression and therapeutic response. A deeper understanding of these mechanisms is expected to support the development of more effective therapeutic strategies, particularly immunotherapy tailored to the patient's biological characteristics.
References
Ahmed, I., & Ismail, N. (2020). M1 and M2 macrophages polarization via mTORC1 influences innate immunity and outcome of Ehrlichia infection. Journal of cellular immunology, 2(3), 1-11. https://doi.org/10.33696/immunology.2.029
Akinsipe, T., Mohamedelhassan, R., Akinpelu, A., Pondugula, S. R., Mistriotis, P., Avila, L. A., & Suryawanshi, A. (2024). Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics. Frontiers in immunology, 15, 1-22. https://doi.org/10.3389/fimmu.2024.1302587
Andersson, P., Yang, Y., Hosaka, K., Zhang, Y., Fischer, C., Braun, H., & Cao, Y. (2018). Molecular mechanisms of IL-33–mediated stromal interactions in cancer metastasis. JCI insight, 3(20), 1-18. https://doi.org/10.1172/jci.insight.122375
Antoni, M. H., & Dhabhar, F. S. (2019). The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer, 125(9), 1417-1431. https://doi.org/10.1002/cncr.31943
Bähr, I., Jahn, J., Zipprich, A., Pahlow, I., Spielmann, J., & Kielstein, H. (2018). Impaired natural killer cell subset phenotypes in human obesity. Immunologic Research, 66(2), 234–244. https://doi.org/10.1007/s12026-018-8989-4
Balgahoom, N., Surjadi, L. M., & Kurniawan, F. (2025). Relationship Between Menarche Age and Breast Cancer Incidence in Adult Women. Jurnal Biomedika dan Kesehatan, 8(3), 263-273. https://doi.org/10.18051/JBiomedKes.2025.v8.263-273
Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M. H., Moradi-Kalbolandi, S., & Farahmand, L. (2020). Breast cancer: Biology, biomarkers, and treatments. International immunopharmacology, 84, 106535. https://doi.org/10.1016/j.intimp.2020.106535
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., ... & Krummel, M. F. (2018). Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature medicine, 24(5), 541-550. https://doi.org/10.1038/s41591-018-0014-x
Brummel, K., Eerkens, A. L., de Bruyn, M., & Nijman, H. W. (2023). Tumour-infiltrating lymphocytes: from prognosis to treatment selection. British journal of cancer, 128(3), 451-458. https://doi.org/10.1038/s41416-022-02119-4
Burugu, S., Asleh-Aburaya, K., & Nielsen, T. O. (2017). Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication. Breast cancer, 24(1), 3-15. https://doi.org/10.1007/s12282-016-0698-z
Cao, H., Huang, Y., Wang, L., Wang, H., Pang, X., Li, K., Chen, T. (2016). Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages. Oncotarget, 7(40), 65441–65453. https://doi.org/10.18632/oncotarget.11761
Chen, X., Wang, M., Yu, K., Xu, S., Qiu, P., Lyu, Z., & Xu, Y. (2023). Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors. Journal of translational internal medicine, 11(3), 226-233. https://doi.org/10.2478/jtim-2021-0050
Chen, Y., Jiang, P., & Geng, Y. (2023). The role of breastfeeding in breast cancer prevention: a literature review. Frontiers in oncology, 13, 1257804. https://doi.org/10.3389/fonc.2023.1257804
Cheng, X. (2024). A comprehensive review of HER2 in cancer biology and therapeutics. Genes, 15(7), 1-15. https://doi.org/10.3390/genes15070903
Chung, Y. W., Kim, S., Hong, J. H., Lee, J. K., Lee, N. W., Lee, Y. S., & Song, J. Y. (2019). Overexpression of HER2/HER3 and clinical feature of ovarian cancer. Journal of Gynecologic Oncology, 30(5), 1–12. https://doi.org/10.3802/jgo.2019.30.e75
Clements, V. K., Long, T., Long, R., Figley, C., Smith, D. M., & Ostrand-Rosenberg, S. (2018). High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells. Journal of Leukocyte Biology, 103(3), 395–407. https://doi.org/10.1002/JLB.4HI0517-210R
De Caluwé, A., Buisseret, L., Poortmans, P., Van Gestel, D., Salgado, R., Sotiriou, C., & Ignatiadis, M. (2021). Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial. BMC cancer, 21(1), 1-9. https://doi.org/10.1186/s12885-021-08601-1
De Mattos-Arruda, L. (2020). PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come. ESMO open, 5(4),1-3. https://doi.org/10.1136/esmoopen-2020-000890
Devericks, E. N., Carson, M. S., McCullough, L. E., Coleman, M. F., & Hursting, S. D. (2022). The obesity-breast cancer link: a multidisciplinary perspective. Cancer and Metastasis Reviews, 41(3), 607-625. https://doi.org/10.1007/s10555-022-10043-5
Dou T, Li J, Zhang Y, Pei W, Zhang B, Wang B, Wang Y and Jia H (2024) The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer. Front. Immunol. 15:1-18. https://doi.org/10.3389/fimmu.2024.1368687
Eruslanov, E. B. (2017). Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer. Cancer Immunology, Immunotherapy, 66(8), 997-1006. https://doi.org/10.1007/s00262-017-1976-0
Evangelista, G. C. M., Salvador, P. A., Soares, S. M. A., Barros, L. R. C., Xavier, F. H. D. C., Abdo, L. M., & Gameiro, J. (2019). 4T1 mammary carcinoma colonization of metastatic niches is accelerated by obesity. Frontiers in oncology, 9, 1-12. https://doi.org/10.3389/fonc.2019.00685
Gao, Y., Song, Z., Jia, L., et al. (2022). Self-amplified ROS production from fatty acid oxidation enhanced tumor immunotherapy by atorvastatin/PD-L1 siRNA lipopeptide nanoplexes. Biomaterials, 291, 121902. https://doi.org/10.1016/j.biomaterials.2022.121902
Gibson, J. T., Orlandella, R. M., Turbitt, W. J., Behring, M., Manne, U., Sorge, R. E., & Norian, L. A. (2020). Obesity-associated myeloid-derived suppressor cells promote apoptosis of tumor-infiltrating CD8 T cells and immunotherapy resistance in breast cancer. Frontiers in immunology, 11, 1-13. https://doi.org/10.3389/fimmu.2020.590794
Giordano, C., La Camera, G., Gelsomino, L. (2020). The biology of exosomes in breast cancer progression: Dissemination, immune evasion and metastatic colonization. Cancers, 12(8), 2179. https://doi.org/10.3390/cancers12082179
Guo, L., Kong, D., Liu, J., Zhan, L., Luo, L., Zheng, W., Zheng, Q., Chen, C., & Sun, S. (2023). Breast cancer heterogeneity and its implication in personalized precision therapy. Experimental Hematology & Oncology, 12(1), 3. https://doi.org/10.1186/s40164-022-00363-1
Harris, A. R., Perez, L. G., Scharping, N. E., & Beatty, G. L. (2024). Towards targeting the breast cancer immune microenvironment. Nature Reviews Cancer, 24(8), 531–548. https://doi.org/10.1038/s41568-024-00714-6
Hazra, A., Bose, P., Sunita, P., & Pattanayak, S. P. (2021). Molecular epigenetic dynamics in breast carcinogenesis. Archives of Pharmacal Research, 44(8), 741–763. https://doi.org/10.1007/s12272-021-01348-0
Hiller, J. G., Cole, S. W., Crone, E. M., Byrne, D. J., Shackleford, D. M., Pang, J. M. B., & Sloan, E. K. (2020). Preoperative β-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial. Clinical cancer research, 26(8), 1803-1811. https://doi.org/10.1158/1078-0432.CCR-19-2641
Im, J. H., Buzzelli, J. N., Jones, K., Franchini, F., Gordon-Weeks, A., & Markelc, B. (2020). FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy. Nature Communications, 11, 1–14. https://doi.org/10.1038/s41467-020-17914-x
Iyengar, N. M., Gucalp, A., Dannenberg, A. J., & Hudis, C. A. (2016). Obesity and cancer mechanisms: Tumor microenvironment and inflammation. Annual Review of Medicine, 74, 421–437. https://doi.org/10.1200/jco.2016.67.4283
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021). Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion. Nature Reviews Cancer, 21(5), 298–312. https://doi.org/10.1038/s41568-021-00339-z
Kundu, R., Chatterjee, S., Chatterjee, S., & Basu, A. (2024). Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Molecular Cancer, 23(1), 70. https://doi.org/10.1186/s12943-024-01990-4
Landry, I., Sumbly, V., & Vest, M. (2022). Advancements in the treatment of triple-negative breast cancer: A narrative review of the literature. Cureus, 14(2), 1–15. https://doi.org/10.7759/cureus.21970
Li, T., Liu, T., Zhu, W., Xie, S., Zhao, Z., Feng, B., & Yang, R. (2021). Targeting MDSC for immune-checkpoint blockade in cancer immunotherapy: current progress and new prospects. Clinical Medicine Insights: Oncology, 15, 1-14. https://doi.org/10.1177/11795549211035540
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019). Cancer-associated fibroblasts build and secure the tumor microenvironment. Frontiers in cell and developmental biology, 7, 60,1-13. https://doi.org/10.3389/fcell.2019.00060
Luo, X., Cheng, C., Tan, Z., Li, N., Tang, M., Yang, L., & Cao, Y. (2017). Emerging roles of lipid metabolism in cancer metastasis. Molecular cancer, 16(1), 1-10. https://doi.org/10.1186/s12943-017-0646-3
Luque, M., Sanz-Alvarez, M., Morales-Gallego, M., Madoz-Gurpide, J., Zazo, S., Dominguez, C., ... & Rojo, F. (2022). Tumor-infiltrating lymphocytes and immune response in HER2-positive breast cancer. Cancers, 14(24), 1-16. https://doi.org/10.3390/cancers14246034
Lyssiotis, C. A., & Kimmelman, A. C. (2017). Metabolic interactions in the tumor microenvironment. Trends in Cell Biology, 27(11), 863–875. https://doi.org/10.1016/j.tcb.2017.06.003
Maliniak, M. L., Cheriyan, A. M., Sherman, M. E., Liu, Y., Gogineni, K., Liu, J., & McCullough, L. E. (2020). Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer. Breast Cancer Research, 22(1), 65. https://doi.org/10.1186/s13058-020-01308-4
Manzo, T., Prentice, B. M., Anderson, K. G., Raman, A., Schalck, A., Codreanu, G. S. (2020). Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells. Journal of Experimental Medicine, 217(8), 1–22. https://doi.org/10.1084/jem.20191920
Monzavi-Karbassi, B., Mohammadi, S., Yazdanifar, M., & Kieber-Emmons, T. (2024). The tumor microenvironment and immune response in breast cancer. International Journal of Molecular Sciences, 25(2), 914. https://doi.org/10.3390/ijms25020914
Muharram, G. G., Darmi, N. F., & Razi, F. (2023). Breastfeeding significant correlated with decreasing of breast cancer risk. Journal of International Surgery and Clinical Medicine, 3(2), 38-42. https://doi.org/10.51559/jiscm.v3i2.45
Mullooly, M., Yang, H. P., Falk, R. T., Nyante, S. J., Cora, R., Pfeiffer, R. M., & Gierach, G. L. (2017). Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue in postmenopausal women. Breast Cancer Research, 19, 8. https://doi.org/10.1186/s13058-016-0787-0
Prajoko, Y. W., Heriyanto, D. S., Amalina, N. D., Dirja, B. T., Susanto, S., Lau, V., & Gunawan, A. N. (2024). Unveiling the genetic landscape: high frequency of pik3ca mutation in luminal a and b breast cancer within the Indonesian population.Research square.1-19. https://doi.org/10.21203/rs.3.rs-4000099/v1
Putri, A. M., Tejo, J., Probowati, W., & Siagian, J. W. (2022). The Association between The Patient’s Age Groups with Stage, Grading, and Molecular Subtype of Breast Cancer. Journal of Medicine and Health, 4(2), 123-130. https://doi.org/10.28932/jmh.v4i2.4554
Ramamonjisoa, N., & Ackerstaff, E. (2017). Characterization of the tumor microenvironment and tumor–stroma interaction by non-invasive preclinical imaging. Frontiers in oncology, 7, 3,1-22. https://doi.org/10.3389/fonc.2017.00003
Rapoport, B. L., Steel, H. C., Hlatshwayo, N., Theron, A. J., Meyer, P. W., Nayler, S., & Anderson, R. (2022). Systemic immune dysregulation in early breast cancer is associated with decreased plasma levels of both soluble co-inhibitory and co-stimulatory immune checkpoint molecules. Frontiers in Immunology, 13, 1-10. https://doi.org/10.3389/fimmu.2022.823842
Risom, T., Glass, D. R., Averbukh, I., Liu, C. C., Baranski, A., Kagel, A., ... & Angelo, M. (2022). Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell, 185(2), 299-310. https://doi.org/10.1016/j.cell.2021.12.023
Sha, R., Kong, X., Li, X., Zhang, H., Wang, Y., et al. (2024). Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: Results from the Global Burden of Disease Study 2021. Biomarker Research, 12, 87. https://doi.org/10.1186/s40364-024-00631-8
Song, P. N., Mansur, A., Dugger, K. J., Davis, T. R., Howard, G., Yankeelov, T. E., & Sorace, A. G. (2020). CD4 T-cell immune stimulation of HER2+ breast cancer cells alters response to trastuzumab in vitro. Cancer Cell International, 20(1), 1-11. https://doi.org/10.1186/s12935-020-01625-w
Sulli, G., Lam, M. T. Y., & Panda, S. (2019). Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends in cancer, 5(8), 475-494. https://doi.org/10.1016/j.trecan.2019.07.002
Sun, Y. S., Zhao, Z., Yang, Z. N., Xu, F., Lu, H. J., Zhu, Z. Y., & Zhu, H. P. (2017). Risk factors and preventions of breast cancer. International journal of biological sciences, 13(11), 1387-1397. https://doi.org/10.7150/ijbs.21635
Taghiloo, S., Norozi, S., & Asgarian-Omran, H. (2022).
The effects of PI3K/Akt/mTOR signaling pathway inhibitors on the expression of immune checkpoint ligands in acute myeloid leukemia cell line. Iranian Journal of Allergy, Asthma and Immunology, 21(2), 178–188. https://doi.org/10.18502/ijaai.v21i2.9225
Takenouchi, Y., Kitakaze, K., Tsuboi, K., & Okamoto, Y. (2020). Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts. Experimental cell research, 391(2), 112010. https://doi.org/10.1016/j.yexcr.2020.112010
Triulzi, T., Bianchi, G. V., Tagliabue, E., & Gianni, L. (2018). HER2 signaling and immune response in breast cancer. Cancers, 15(6), 1724. https://doi.org/10.1080/2162402x.2018.1512942
Walker, A. K., Martelli, D., Ziegler, A. I., Lambert, G. W., Phillips, S. E., Hill, S. J., & Sloan, E. K. (2019). Circulating epinephrine is not required for chronic stress to enhance metastasis. Psychoneuroendocrinology, 99, 191-195. https://doi.org/10.1016/j.psyneuen.2018.09.012
Wang, Z., Aguilar, E. G., Luna, J. I., Dunai, C., Khuat, L. T., Le, C. T., & Monjazeb, A. M. (2019). Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature Medicine, 25(1), 141–151. https://doi.org/10.1038/s41591-018-0221-5
Xu, J., & Niu, T. (2020). Natural killer cell-based immunotherapy for acute myeloid leukemia. Journal of Hematology & Oncology, 13(1), 167. https://doi.org/10.1186/s13045-020-00996-x
Yao, P., Ni, Y., & Liu, C. (2020).Long non-coding RNA 691 regulated PTEN/PI3K/AKT signaling pathway in osteosarcoma through miRNA-9-5p. OncoTargets and Therapy, 13, 4597–4606. https://doi.org/10.2147/OTT.S249827
Yiallourou, A., Pantavou, K., Markozannes, G., Pilavas, A., Georgiou, A., Hadjikou, A., Economou, M., Christodoulou, N., Letsos, K., Khattab, E., Kossyva, C., Constantinou, M., Theodoridou, M., Piovani, D., Tsilidis, K. K., Bonovas, S., & Nikolopoulos, G. K. (2024). Non-genetic factors and breast cancer: An umbrella review of meta-analyses. BMC Cancer, 24, 903. https://doi.org/10.1186/s12885-024-12641-8
Yu, P. F., Huang, Y., Han, Y. Y., Lin, L. Y., Sun, W. H., Rabson, A. B.,& Shi, Y. F. (2017). TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene, 36(4), 482-490. https://doi.org/10.1038/onc.2016.217
Zhang, C., Yue, C., Herrmann, A., Song, J., Egelston, C., Wang, T., & Yu, H. (2020). STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth. Cell metabolism, 31(1), 148-161. https://doi.org/10.1016/j.cmet.2019.10.013
Zheng, Y., Ren, S., Zhang, Y., Liu, S., Meng, L., Liu, F., ... & Sang, M. (2022). Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4. Cancer cell international, 22(1), 1-13. https://doi.org/10.1186/s12935-022-02686-9
Zipinotti dos Santos, D., de Souza, J. C., Pimenta, T. M., da Silva Martins, B., Junior, R. S. R., Butzene, S. M. S., & Rangel, L. B. (2023). The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape. Cell Communication and Signaling, 21(1), 161. https://doi.org/10.1186/s12964-023-01178-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Maula Syakira, Nisa Ulmafhigrah, Firdus Firdus, Rosnizar Rosnizar (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
